Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.
The introduction of real-time quantitative PCR (qPCR) in the early 1990s opened the door for quantitative gene expression analysis. Still, qPCR depends on standard curves, allowing only relative ...
Medical Device Network on MSN
Countable Labs raises $26M for PCR technology advancement
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
Quantitative polymerase chain reaction (qPCR) has become a cornerstone technique for the sensitive and precise measurement of gene expression. By monitoring DNA amplification in real time, qPCR ...
Gene expression experiments measure changes in RNA transcript levels to compare how genes are up- or down-regulated across different biological conditions and are a crucial element to many research ...
Countable Labs raises $26 million to develop advanced single-molecule PCR tools, expanding precision diagnostics for global ...
PCR, or Polymerase Chain Reaction, is a revolutionary molecular biology technique that allows for the rapid amplification of specific DNA sequences. It is an essential tool in various fields, ...
Association of RNA-sequencing signatures with clinical outcomes of pembrolizumab + chemotherapy in patients with metastatic nonsquamous non–small cell lung cancer (NSCLC) enrolled in the phase 2 ...
Evaluating the outcome of cardiovascular risk factors in breast cancer patients. Neoadjuvant penpulimab combined with taxanes and carboplatin in triple-negative breast cancer: A single-arm, open-label ...
Proteins are critical to life—and to industry. There are countless proteins that could be engineered to treat and even cure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results